Pathogenesis and Diagnosis of Viral Infection Flashcards

1
Q

Entry of Virus

A
  • Must overcome innate defences to enter body: physical & immunological
  • Different viruses adopt different strategies & have different portals of entry
  • Although a single virus may use several entry routes, which may depend on host species
  • E.g. Influenza infection in birds occurs via faecal/oral route & by respiratory route in people
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Skin

A
  • In general, skin is an effective barrier unless breached by abrasions or bites (rabies)
  • Parapox virus can enter via the skin–> Orf infections in goats & sheep- zoontotic
  • Papillomaviruses–> warts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Respiratory

A
  • Defences: mucociliary escalator, resident commensal bacteria in upper respiratory tract, Sneezing & coughing - Innate immunity (e.g. alveolar macrophages, complement, cytokines, Natural Killer cells)
  • Transmission: Aerosolized droplets expelled or contact with saliva from infected individual
  • Examples: Influenza, FMDV, Rhinovirus, Adenovirus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Alimentary

A
  • Defences: low pH in stomach, bile, enzymes & commensal microbiota
  • Examples: Norovirus, Classical Swine Fever
  • Prion (scrapie/BSE in contaminated food)
  • Feline Infectious Peritonitis (FIP)- (a coronavirus which is resistant to trypsin & low pH and can bypass gastric environment)
  • Rotavirus (adapted so when proteolytic enzymes cleave it activated)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Blood

A
  • Transmission:
  • Via hematophagous insects- Bluetongue, Schmallenberg & West Nile Virus
  • Via iatrogenic (result of medical error) transfer- Hepatitis B Virus, HIV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Transplacental

A
  • Viraemic pregnant animals can transmit virus to fetus in utero/ via colostrum/ perinatally through secretions/ transplacentally (vertical transmission)
  • Special case that avoids environmental shedding & transmission
  • Advantages: Infects fetus before Immune System is developed, therefore sees antigen as self –> don’t mount immune defence against it –> ill thrifty/ poor doers
  • Examples: Pestiviruses (BVD Virus & Classical Swine Fever) & PRRS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Local Infections

A

Replication occurs in epithelium at initial infection site. Some cell-cell spread occurs but virus doesn’t disseminated–> other tissues

  • Usually acute (short incubation period & short duration)
  • Site of shedding = site of entry
  • Examples: para/influenza infections, rotaviral/ coronal infections, some pox & papilloma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Systemic Infections

A

Local replication followed by spread to other sites (dissemination via lymph/ blood/ nerves) –> secondary sites of replication

  • Allows entry & exit routes to differ (E.g. FMDV (foot and mouth)- enters via oropharynx route but can be shed in milk etc)
  • More severe pathology generally (longer incubation period)
  • Greater involvement of adaptive immune response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Spread in Lymph

(systemic spread)

A
  • E.g. can breach basement membrane–> sub epithelial & migrate within phagocytic Leukocytes–> lymphatic system
  • Or an disseminate from alimentary tract via M cells –> MALT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hematogenous Spread

(systemic Spread)

A
  • Viremia:

-Primary viremia- (presence of virus in blood) spread from site of entry target tissue

-Secondary viremia- may occur following replication in secondary sites ↑ viral titres & dissemination

  • Virus may be:
  • Free in serum (FMDV)
  • Or ‘cell associated’- carried in macrophages (canine distemper)/ lymphoycytes (FIV)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Spread via Nerves

(systemic)

A

Rabies- Introduced via bite

  • Primary replication in muscle cells–> motor nerves to reach CNS–> Further replication in spinal cord & brain–> enters salivary gland for onwards transmission
  • Rabies gets past the BBB but not Ab’s
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Shedding

(systemic)

A
  • Critical step for transmission to a new host
  • Generally a virus reaches highest titre in organ tissues from which its shed
  • Often, the sites of entry & exit are the same BUT not always, e.g. some systemic infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Viral Tropism

A
  • Cellular tropism- preference of some viruses for particular cells- HIV has preference for RBCs.
  • Tissue tropism- preference particular tissue- Influenza generally affects lung tissue.
  • Host tropism- narrow= affect 1 species, but some can affect a number- ebola (bats & people)

Determined by:

  • Susceptibility: Appropriate cell surface receptors for entry (susceptibility)
  • Permissivity: Requirements of virus for differentially expressed intracellular gene products to complete the infection
  • Accessibility
  • Overcoming host immune defences
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mechanisms leading to Pathology

A
  • Viral fitness is determined by survival & transmission: not advantageous to disable the host
  • Where viruses & hosts have co-evolved, often see minimal disease E.g. myxomatosis –> ↓ virulence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Viral Pathology

(DIRECT EFFECTS)

A

1. Cytopathic effects (CPE)- damage to host cell caused by virus. Changes usually visible by light microscopy- use a plaque assay. Severity of disease not always linked to CPE seen in cell culture - Effects of tissue damage / inflammation depends on organ affected (may have large reserve e.g. Liver/ tolerate damage better)

Mechanisms underlying CPE:

  • ‘Host cell shut-off’
  • Lysosomal damage
  • Cell membrane abnormalities (lose morphology)
  • Syncytia formation (E.g. measles, CDV, herpesvirus, EIA virus)
  • Formation of ‘inclusion bodies’ (E.g. negri bodies in rabies virus infections)

2. Cytocidal effects (cell death)- Via (i) cell lysis (ii) apoptosis (iii) deadly CPE

3. Cell transformation (i.e. uncontrolled growth). Can cause neoplasia-

  • Retroviruses (via insertional mutagenesis where provirus inserts into host DNA/ oncogene expression)
  • Papillomaviruses (Bovine–> warts, Human–> cervical cancer)
  • Herpesviruses
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Virus Indirect Effects

A

Immune Mediated Pathology

  • Immune cytolysis of infected cells= essential to recovery, BUT–> damage & clinical signs often consequence

of immune response (e.g. cytokines are endogenous pyrogens)

  • Immunopathology may be due to Type I-IV hypersensitivity reactions (CTLs, CD4 cells, Antibody), e.g.
  • CTLs (cytotoxic T- lymphocytes): Myocarditis caused by coxsackievirus B infection of mice requires the presence of CTLs
  • CD4+ T cells: induce cytokines & activate effector cells. Recruited neutrophils and mononuclear cells release proteolytic enzymes, free radicals & cytokines
  • Antibody (Type III): Dengue virus, Feline Infectious Peritonitis virus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Iceberg Concept

A
  • The Iceberg Concept- the majority of viral infections pass unnoticed
  • Disease is determined by: host, viral & environmental factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Host Factors

(disease)

A
  • Age
  • Gender
  • Nutritional status
  • Level of productivity (e.g. high-yielding dairy cows)
  • Species/ breed resistance or susceptibility – Immunity (from vaccination/ previous infections)
  • Geographical origin (e.g. if imported may be naïve to local diseases)
  • Physiological stress (e.g. weaning/ pregnancy/ concurrent disease/ movement of animals)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Viral Factors

(disease)

A
  • Virulence factors (e.g. viral immunomodulators) – Classes of viral virulence genes:
  • Alter Replication
  • Enable evasion of host’s defence mechanisms (–> ↑pathogenicity & cross species transmission)

E.g. Vaccinia virus–> immunomodulatory proteins which inhibit the inflammatory & inhibitory IRs

  • Alter spread within the host
  • Directly toxic (e.g. NSP4 enterotoxin of rotaviruses)
  • Endemic or exotic
  • Transmission route: Insect vector, fomites, air-borne, feco-oral
  • Does pathogen cause immuno-suppression? Tropism for immune cells (HIV/FIV and CD4 cells, IBD virus
  • Are there co-infections with multiple pathogens
  • Infectiousness (R0: how many onward infections does each case cause)
20
Q

Environmental Factors

(disease)

A
  • Contamination (toxins, industrial waste, fecal waste)
  • Climatic (impacts pathogen e.g. range of vector-borne disease, environmental stability of pathogen, AND host e.g. physiological stress to temperature extremes)
  • Exposure to insect vectors
  • Quality of pasture/ feed
  • Stocking density (impacts ease of transmission & dose)
  • Management changes (e.g. imported animals/ new feedstuff)
  • Veterinary policy (e.g. vaccination programmes)
21
Q

Acute Infections

A

Outcomes:

  1. Infection cleared by IS–> recovery
  2. Death

Examples: Influenza, rotavirus, whooping cough & pox

22
Q

Perisitent Latent Infection

A
  • Potential to reactivate (i.e. switch from latent–> productive infection) usually due to immunosuppression / external stimuli (sunlight, stress)
  • Latency associated transcripts: Different genetic program

in sites of latency (↓ MHC expression, block apoptosis).

No viral protein synthesis/ infectious virus production.

  • A good strategy for transmission to naïve hosts

Examples: Infectious Bovine Rhinotracheitis (Bovine Herpes virus-1).

-IBR invades via nasopharynx or genital tract, replicates in epithelial cells causing ulcerations & vesicles. Ascends sensory nerve fibres & establishes latency in ganglionic neurons. Periodic reactivation.

23
Q

Chronic Latent Infection

A

Types:

  • Persistent infection with shedding. E.g. tape worms, Epstein- Barr virus
  • Persistent slow infection following acute infection. E.g. slowly progressive disease of FeLV
  • Persistent slow infection (no acute phase) E.g. Creuzfeldt-jakob disease, Jaagsiekte sheep Retrovirus infection (JSRV)
24
Q

Factors involved in Persistence

A
  • Immune evasion (though seen for acute infections also)
  • Tolerance (e.g. avian leukosis virus, BVDV)
  • Virus variants (RNA viruses e.g. HIV)
  • ‘Privileged sites’
  • Immune suppression
25
Q

Koch’s Postulates

A

Published in 1980, 4 criteria to establish causative relationship between microbe and specific disease:

  1. The microbe must be found in organisms afflicted by the disease, but not in healthy organisms
  2. The organism must be isolated from the disease host and grown in culture
  3. The cultured microbe should cause disease when introduced into a healthy organism
  4. The same organism must be re-isolated from the experimentally infected host
26
Q

Limitations to Koch’s Postulates

A
  • Some microbes with pathogenic potential can be found in asymptomatic hosts (carriers):
  • Vibrio cholera, many viruses (not discovered in Koch’s day), Poliovirus causes paralytic disease in ~1% ofthose infected, FeLV causes leukaemia in ~1% persistent infections
  • Not all pathogens can be grown in culture or no suitable animal model exists
  • Not all potential hosts exposed to infection will develop disease
27
Q

Kochs Postulates adapted for 21st Century

A
  • Present in most cases of an infectious disease
  • Found preferentially in those organs known to be diseased (not those lacking pathology)
28
Q

Sampling the Host Immune System

(Diagnosis)

A

Blood sample

-Clotted sampled for serum

-EDTA anticoagulant for cells (haematology)

Tissue Biopsy

  • Lymph Node
  • Lesion

Sampling- If unsure contact lab prior to sampling to find out: Amount of material required, suitable swab material, transport medium (with/without antibiotics), refrigeration

29
Q

Diagnostic Methods Dependent On:

A

Detection of pathogen at site of infection:

  • Observation of viral pathogenesis (histopathology)
  • Direct visualisation of virus particles (morphology)
  • Presence of virus genome (nucleic acid)
  • Presence of virus antigen (protein)

Evidence of host immune response to infection:

  • Antibodies in serum (serology)
  • (Cell-mediated immune response)
30
Q

Virus Isolation

A

Grow virus in the laboratory, observe viral pathogenesis

Important Concepts:

  • Viruses need cells to replicate
  • Virus has to attach to cell to infect
  • Viral surface protein(s) bind to receptor on host cell surface
  • Species specificity and tissue specificity
  • Cytopathic effects on cultured cells E.g. cytotoxicity, inclusion bodies & syncytia

​​Advantages:

  • Virus is amplified and therefore easier to detect

Disadvantages:

  • Need to have a suspect in mind
  • Takes several days (depending on virus)
  • Requires live virus
  • Not all viruses can be cultured
  • Further identification required
31
Q

Electron Microscopy

A

Negative Staining

  • Uses heavy metal stains that don’t bind to sample but stain the background
  • Stain is non-permeable for electrons & appears dark on image
  • Virus= permeable & appears light in colour
  • Can Identify virus based on its morphology: Type of capsid symmetry & whether it is naked/ enveloped

Advantages:

  • Can be used for viruses that can’t be cultured - Allows identification of new agents

Disadvantages:

  • Requires specialised equipment & experienced personnel
  • Low sensitivity may require concentration of sample
  • Often requires purification of sample
32
Q

Presence of Viral Genome: PCR

A
  • Polymerase chain reaction (PCR)
  • Based on ability of Taq polymerase to amplify DNA
  • Use short oligonucleotide primers, specific for virus sequence
  • Generation of amplicon of predicted size indicates presence of virus nucleic acid in sample.
  • DNA vs RNA viruses - detection of RNA viruses
  • PCR template = DNA or cDNA
  • RNA might need to be converted–> cDNA via Reverse Transcription-PCR

Advantages:

  • Very sensitive, can use very small amounts of starting material
  • Does not require live virus
  • Specific as primers are designed for target DNA
  • Real time PCR- allows quantification, uses fluorescent technology- quicker as no gel stage

Disadvantages:

  • Very sensitive, danger of contamination (can–> false positives)
33
Q

Using Ab Specific for VIral Proteins

(Immunoassays)

A
  • Monoclonal antibodies: specific for one antigenic epitope
  • Polyclonal antibodies: mixture of antibodies, detect several epitopes, e.g. anti-serum from immunised animal
34
Q

Antigen ELISA

(Immunoassays)

A

(biological fluids)- aka a Sandwich ELISA

  • Plates coated with antibody specific to virus
  • Virus in sample binds to antibody
  • Second virus-specific, enzyme-labelled antibody is added
  • Enzyme acts on substrate to generate a colour change
35
Q

Immunohisto/cytochemistry

(Immunoassay)

A

-(tissue sections/ cells, smears)

  • Virus antigen in cells is detected by specific antibody
  • Antibody carries a label:
  • Either fluorescent (immunofluorescence assay)
  • Or enzyme which reacts with colour substrate (immunoperoxidase assay)

Example: BVDV can be detected in epithelium of ear notch biopsy

36
Q

Immunochromatography

A

(biological fluids)

  • Rapid Immunomigration used- FeLV testing
  • Fast, easily transportable kit
37
Q

Immunoassays are all:

A

Advantages:

  • fast
  • Does not require live virus
  • Specific

Disadvantages:

-No amplification included, relatively ↓ sensitivity

38
Q

Measuring Ab’s in Serum

A

Diagnostic methods based on identifying host immune response

  • Antibodies are evidence of previous infection
  • Usually antibodies are detectable from 1-2 weeks post exposure- lag phase
39
Q

Ideally 2 samples obtained from Serum Antibody

(When measuring IgG)

A
  1. When animal shows clinical signs of disease (acute sample)
  2. 2-3 weeks later when animal has recovered and produced antibodies (convalescent sample)
  • But useful for:
  • Diagnosis of persistent infections e.g. FIV
  • Checking disease-free status of herd
  • Screening for exposure to exotic diseases
  • Assessing vaccination status
  • Rising antibody titre shows that recent infection has taken place
40
Q

Measuring IgM

A
  • Some tests are able to detect IgM which indicates an early immune response to infection and therefore requires only one sample (at time of clinical signs)
  • IgM is formed primarily in infection
41
Q

Netralisation Assay

(Serum)

A
  • Serum sample is mixed with virus
  • Antibodies in patient’s sample bind to virus
  • Mixture is added to cells
  • If antibodies present: virus can’t infect cells as bound by antibodies, cells remain healthy
  • If no antibodies present: virus infects cells, cytopathic effect is detected
42
Q

Haemagglutination Assay

(Serum Ab)

A
  • Based on ability of some viruses to agglutinate red blood cells (particularly influenza)
  • Serum sample is mixed with virus
  • If antibodies are present in the serum they bind to virus
  • Red blood cells are added to mixture
  • If antibodies were present in serum: virus is bound and red blood cells don’t agglutinate
  • If no antibodies were present virus is free and can agglutinate red blood cells
43
Q

Antibody ELISA

A
  • Plate is coated with antigen (whole virus/ purified virus protein)
  • Antibody in serum sample binds to antigen
  • Second antibody which recognises IgG is added
  • Second antibody carries an enzyme label
  • Enzyme converts colour substrate and colour change is detected
44
Q

Antibody Detection

(adv/Disadv.)

A

Advantages:

  • Cheap
  • Specific
  • Relatively Sensitive

Disadvantages

  • Majority of Tests only allow retrospective diagnosis
  • Negative test does not mean no exposure [NB LAG PHASE]
  • Antibody Titre
45
Q

Antibody Titre

A
  • To assess quantity of antibodies in a patient’s sample
  • Serial dilution of serum sample
  • All dilutions are tested for antibodies
  • Last positive dilution gives the antibody titre
46
Q
A